home / stock / tril / tril quote
Last: | $18.44 |
---|---|
Change Percent: | 2.62% |
Open: | $17.92 |
Close: | $18.44 |
High: | $18.49 |
Low: | $17.83 |
Volume: | 25,934,077 |
Last Trade Date Time: | 11/16/2021 04:56:30 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$18.44 | $17.92 | $18.44 | $18.49 | $17.83 | 25,934,077 | 11-16-2021 |
$17.97 | $17.95 | $17.97 | $17.97 | $17.9 | 870,334 | 11-15-2021 |
$17.91 | $17.82 | $17.91 | $17.91 | $17.82 | 967,602 | 11-12-2021 |
$17.82 | $17.78 | $17.82 | $17.91 | $17.71 | 1,309,751 | 11-11-2021 |
$17.83 | $17.75 | $17.83 | $17.96 | $17.74 | 1,255,087 | 11-10-2021 |
$17.83 | $17.73 | $17.83 | $17.9 | $17.72 | 1,611,526 | 11-09-2021 |
$17.69 | $17.9 | $17.69 | $17.99 | $17.68 | 1,981,363 | 11-08-2021 |
$17.89 | $17.9 | $17.89 | $17.995 | $17.84 | 1,457,745 | 11-05-2021 |
$17.85 | $17.87 | $17.85 | $17.94 | $17.81 | 1,029,818 | 11-04-2021 |
$17.85 | $17.87 | $17.85 | $17.93 | $17.8 | 789,035 | 11-03-2021 |
$17.86 | $17.98 | $17.86 | $18.03 | $17.84 | 1,093,405 | 11-02-2021 |
$18 | $18.07 | $18 | $18.12 | $17.97 | 1,673,620 | 11-01-2021 |
$18.11 | $18.02 | $18.11 | $18.12 | $17.95 | 736,029 | 10-29-2021 |
$17.94 | $17.95 | $17.94 | $18 | $17.859 | 503,914 | 10-28-2021 |
$17.94 | $17.91 | $17.94 | $18 | $17.91 | 629,197 | 10-27-2021 |
$17.96 | $17.91 | $17.96 | $17.97 | $17.88 | 561,010 | 10-26-2021 |
$17.91 | $17.88 | $17.91 | $17.96 | $17.85 | 516,846 | 10-25-2021 |
$17.91 | $17.88 | $17.91 | $17.94 | $17.8 | 655,310 | 10-22-2021 |
$17.86 | $17.75 | $17.86 | $17.91 | $17.75 | 2,923,656 | 10-21-2021 |
$17.75 | $17.65 | $17.75 | $17.75 | $17.61 | 375,647 | 10-20-2021 |
News, Short Squeeze, Breakout and More Instantly...
Trillium Therapeutics Inc. Company Name:
TRIL Stock Symbol:
NASDAQ Market:
Trillium Therapeutics Inc. Website:
The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substance...
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributors Keith Speights and Brian Orelli explain why the news of a discontinued drug from the pharmaceutical giant hasn't shaken investors. Keith Speights: Pf...
CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL) , a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, is pleased to announce...